Calcium sodium phosphosilicate (CSPS) is a bioactive glass material that alleviates dentin hypersensitivity and is postulated to confer remineralization of caries lesions. This single-centre, randomized, single (investigator)-blind, placebo-controlled, crossover, in situ study explored whether the addition of 5% CSPS to a nonaqueous fluoride (F) such as sodium monofluorophosphate (SMFP)-containing dentifrice affects its cariostatic ability. Seventy-seven subjects wore 4 gauze-covered enamel specimens with preformed lesions (2 surface-softened and 2 subsurface) placed buccally on their mandibular bilateral dentures for up to 4 weeks. Subjects brushed twice daily with 1 of the 5 study dentifrices: 927 ppm F/5% CSPS, 927 ppm F/0% CSPS, 250 ppm F/0% CSPS, 0 ppm F/5% CSPS, or 0 ppm F/0% CSPS. Specimens were retrieved after either 21 (surface-softened lesions; analyzed by Knoop surface microhardness [SMH]) or 28 days (subsurface lesions; analyzed by transverse microradiography). The enamel fluoride uptake was determined for all specimens using a microbiopsy technique. The concentrations of fluoride and calcium in gauze-retrieved plaque were also evaluated. Higher dentifrice fluoride concentrations led to greater remineralization and fluoridation of both lesion types and increased plaque fluoride concentrations. CSPS did not improve the cariostatic properties of SMFP; there were no statistically significant differences between 927 ppm F/5% CSPS and 927 ppm F/0% CSPS in percent SMH recovery (p = 0.6788), change in integrated mineral loss (p = 0.5908), or lesion depth (p = 0.6622). Likewise, 0 ppm F/5% CSPS did not provide any benefits in comparison to 0 ppm F/0% CSPS. In conclusion, CSPS does not negatively impact nor does it improve the ability of an SMFP dentifrice to affect remineralization of caries lesions.

1.
Burwell AK, Litkowski LJ, Greenspan DC: Calcium sodium phosphosilicate (NovaMin®): remineralization potential. Adv Dent Res 2009;21:35-39.
2.
Cochrane NJ, Cai F, Huq NL, Burrow MF, Reynolds EC: New approaches to enhanced remineralization of tooth enamel. J Dent Res 2010;89:1187-1197.
3.
Duckworth RM, Morgan SN, Ingram GS, Page DJ: Oral fluid reservoirs and their relationship to anticaries efficacy; in Embery G, Rolla G (eds): Clinical and Biological Aspects of Dentifrices. Oxford, Oxford University Press, 1992, pp 91-104.
4.
Edgar WM, Ingram GS, Morgan SN: Fluoride in saliva and plaque in relation to fluoride in drinking water and in dentifrice; in Embery G, Rolla G (eds): Clinical and Biological Aspects of Dentifrices. Oxford, Oxford University Press, 1992, pp 157-163.
5.
Efflandt SE, Magne P, Douglas WH, Francis LF: Interaction between bioactive glasses and human dentin. J Mater Sci Mater Med 2002;26:557-565.
6.
Featherstone JDB: Dental caries: a dynamic disease process. Aust Dent J 2008;53:286-291.
7.
Featherstone JDB, Zero DT: An in situ model for simultaneous assessment of inhibition of demineralization and enhancement of remineralization. J Dent Res 1992;71:804-810.
8.
Gelhard TBFM, ten Cate JM, Arends J: Rehardening of artificial enamel lesions in vivo. Caries Res 1979;13:80-83.
9.
Gendreau L, Barlow AP, Mason SC: Overview of the clinical evidence for the use of NovaMin in providing relief from the pain of dentin hypersensitivity. J Clin Dent 2011;22:90-95.
10.
Gjorgievska ES, Nicholson JW: A preliminary study of enamel remineralization by dentifrices based on Recalden (CPP-ACP) and Novamin (calcium-sodium-phosphosilicate). Acta Odontol Latinoam 2010;23:234-239.
11.
Grootveld M, Silwood CJL, Winter WT: High-resolution 1H NMR investigations of the capacity of dentifrices containing a “smart” bioactive glass to influence the metabolic profile of and deliver calcium ions to human saliva. J Biomed Mater Res B Appl Biomater 2009;91:88-101.
12.
Jones SB, Parkinson CR, Jeffery P, Davies M, Macdonald EL, Seong J, West NX: A randomised clinical trial investigating calcium sodium phosphosilicate as a dentine mineralising agent in the oral environment. J Dent 2015;43:757-764.
13.
Knoop F, Peters CG, Emerson WB: A Sensitive Pyramidal-Diamond Tool for Indentation Measurements. J Res Natl Bur Stand 1939;23:39-61.
14.
Koulourides T, Phantumvanit P, Munksgaard EC, Housch T: An intraoral model used for studies of fluoride incorporation in enamel. J Oral Pathol 1974;3:185-196.
15.
Lippert F, Butler A, Lynch RJ: Characteristics of methylcellulose acid gel lesions created in human and bovine enamel. Caries Res 2013;47:50-55.
16.
Lippert F, Lynch RJ: Comparison of Knoop and Vickers surface microhardness and transverse microradiography for the study of early caries lesion formation in human and bovine enamel. Arch Oral Biol 2014;59:704-710.
17.
Lynch RJM, Mony U, ten Cate JM: Effect of lesion characteristics and mineralising solution type on enamel remineralisation in vitro. Caries Res 2007;41:257-262.
18.
Lynch RJM, Smith SR: Remineralization agents - new and effective or just marketing hype? Adv Dent Res 2012;24:63-67.
19.
Martinez-Mier EA, Buckley CB, Chandrappa P, Soto-Rojas AE: Development of a standard fluoride analytical method for dental plaque. J Dent Res 2010;89:931.
20.
Martinez-Mier EA, Cury J, Heilman J, Levy SM, Li Y, Maguire J, Margineda A, O'Mullane D, Phantumvanit P, Soto AE, Stookey GK, Villa A, Wefel JS, Whitford GM, Zero DT, Zhang W, Zohouri V: Development of standard fluoride analytical methods: direct analysis. Caries Res 2004;38:372.
21.
Mellberg JR, Petrou ID, Grote NE: Findings from an in situ thin-section sandwich model for evaluating cariogenic and anti-cariogenic activity. J Dent Res 1992;71:850-855.
22.
Mukai Y, Lagerweij MD, ten Cate JM: Effect of a solution with high fluoride concentration on remineralization of shallow and deep root surface caries in vitro. Caries Res 2001;35:317-324.
23.
Proskin HM, Chilton NW, Kingman A: Interim report of the ad hoc committee for the consideration of statistical concerns related to the use of intra-oral models in submissions for product claims approval to the American Dental Association. J Dent Res 1992;71:949-952.
24.
Robinson C, Shore RC, Brookes SJ, Strafford S, Wood SR, Kirkham J: The chemistry of enamel caries. Crit Med Oral Biol Med 2000;11:481-495.
25.
Sakkab NY, Cilley WA, Haberman JP: Fluoride in deciduous teeth from an anti-caries clinical study. J Dent Res 1984;63:1201-1205.
26.
Strang R, Damato FA, Creanor SL, Stephen KW: The effect of baseline lesion mineral loss on in situ remineralization. J Dent Res 1987;66:1644-1646.
27.
Taves DR: Separation of fluoride by rapid diffusion using hexamethyldisiloxane. Talanta 1968;15:969-974.
28.
ten Cate JM: Contemporary perspective on the use of fluoride products in caries prevention. Br Dent J 2013;214:161-167.
29.
Wefel JS: NovaMin®: likely clinical success. Adv Dent Res 2009;21:40-43.
30.
White DJ: Use of synthetic polymer gels for artificial carious lesion preparation. Caries Res 1987;21:228-242.
31.
Zero DT: In situ caries models. Adv Dent Res 1995;9:214-230.
32.
Zero DT, Rahbek I, Fu J, Proskin HM, Featherstone JDB: Comparison of the iodide permeability test, surface microhardness test and mineral dissolution of bovine enamel following acid challenge. Caries Res 1990;24:181-188.
33.
Zero DT, Zhang JZ, Harper DS, Wu M, Kelly S, Waskow J, Hoffman M: The remineralizing effect of an essential oil fluoride mouthrinse in an intraoral caries test. J Am Dent Assoc 2004;135:231-237.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.